loader2
Login Open ICICI 3-in-1 Account
IPOLogoImag

ENTERO HEALTHCARE SOLUTIONS IPO

IPO Details

-
-
11 Shares
-
₹ 1195 – 1258
₹ Up to 1600 Cr

Issue timeline

  • -
  • 14-Feb-2024
  • 15-Feb-2024
  • 15-Feb-2024
  • 16-Feb-2024

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

About Company

- They are amongst the top three healthcare products distributors in India in terms of revenue in Financial Year 2022(Source: CRISIL Report)

- They offer both demand generation and demand fulfilment solutions to healthcare product manufacturers.

- Achieved the fastest scale-up of operations among healthcare products distributors in India

- As of March 31, 2023, they have supply relationships with over 1,900 healthcare product manufacturers that gives access to over 64,500 product stock keeping units (“SKUs”).

Strengths & Risks

Strengths (2)

Operate in the large and highly fragmented Indian healthcare products distribution market

According to the CRISIL Report, the target addressable market for pharmaceutical distributors in India is valued at ₹2.7 trillion in the FY23 and is expected to grow at 10% to 11% CAGR from the FY23 to the FY28.They believe that they will be able to benefit from the market consolidation in India, and continue to expand business through future strategic acquisitions of local distributors.(Source: Company DRHP)

Risks (2)

They have in the past, and may in the future, experience losses.
They have experienced losses in the FY21, FY22, FY23. These losses have primarily arisen due to total expenses being higher than total income for these periods. These losses also include expenses towards COVID-19 related inventory write-offs and losses relating to scaled down ancillary business. If they are unable to generate adequate revenue growth and manage their expenses, they may continue to incur losses in the future.(Source: Company DRHP)

Financials

Industry Overview

- Indian healthcare market to clock 11-12% CAGR between FY23 and FY28  : The Indian healthcare industry, grew exponentially,logging a 10-11% CAGR, between FY17 and FY23. With an ageing population, an increased incidence of lifestyle diseases, greater healthcare awareness, technology adoption, and a growing affluent middle class serving as some of the key drivers, the market is expected to clock an 11-12% CAGR between fiscals 2023 and 2028, reaching ₹16.5-17.5 trillion in fiscal 2028.
- India is a global hub for pharmaceutical manufacturing: The Indian pharmaceutical industry is the world’s third largest by volume and was valued at ₹3.6-3.8 trillion (including bulk drugs and formulation exports) as of last fiscal. India has a complete ecosystem for the development and manufacturing of pharmaceuticals, with companies having state-of-the-art facilities and skilled/ technical manpower. Moreover, the country has several renowned pharmaceutical educational and research institutes and a robust ecosystem of allied industries(Source: Company DRHP)

Entero Healthcare Solutions IPO FAQs

What is the minimum lot size and investment required for Entero Healthcare Solutions IPO?

The lot size is 11 shares and minimum investment required is Rs.13,838 for Entero Healthcare Solutions IPO

Entero Healthcare Solutions IPO is mainboard IPO of issue size up to Rs.1600 Crores

Entero Healthcare Solutions IPO issue dates are from 09th – 13th Feb, 2024

The allotment date is 14th Feb, 2024 and listing date is 16th Feb,2024 for Entero Healthcare Solutions IPO

Head to IPO section on ICICI Direct website and select Entero Healthcare Solutions IPO. Enter and submit bid details and then click on proceed to apply once details are verified. It’s that simple!!

View More

*The financials mentioned above are sourced from DRHP/ RHP documents.